Medicine News and Research

RSS

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use.

22 May 2023

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.

22 May 2023

Study helps clarify the underlying cause of chest symptoms in angina

An intensive study into the treatment of angina has found that the use of tests for small blood vessel function in the heart clarify the underlying cause of the condition.

22 May 2023

Hand-gesture decoding using data from noninvasive brain imaging

Researchers from University of California San Diego have found a way to distinguish among hand gestures that people are making by examining only data from noninvasive brain imaging, without information from the hands themselves.

19 May 2023

Combining generative AI and quantum computing to accelerate drug discovery

Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it combined two rapidly developing technologies, quantum computing and generative AI, to explore lead candidate discovery in drug development and successfully demonstrated the potential advantages of quantum generative adversarial networks in generative chemistry.

19 May 2023

TWILIGHT trial reveals the impact of DAPT and ticagrelor monotherapy after percutaneous coronary intervention

New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent coronary revascularization, major adverse cardiac and cerebrovascular events (MACCE) and a lower risk of net adverse clinical events (NACE) compared with duel antiplatelet therapy (DAPT).

19 May 2023

Study finds significant amount of clotting in the arteries of patients with STEMI and COVID-19

The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

New Jersey's Medicaid reforms spurred increases in buprenorphine prescriptions to combat opioid addiction

Reforms to New Jersey's Medicaid program successfully spurred ongoing increases in buprenorphine prescriptions for the treatment of opioid addiction, according to a Rutgers analysis.

19 May 2023

Researchers discover sex-specific genes, molecular pathways that contribute to Alzheimer's disease progression

Alzheimer's Disease (AD) is a complex neurodegenerative illness with genetic and environmental origins.

19 May 2023

Study reports improved deliverability, tracking, and deployment of next-generation Evolut FX TAVR system

Results from the Evolut FX TAVR (Transcatheter Aortic Valve Replacement) Clinical Survey were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Tailored revascularization strategies can help improve outcomes for patients with chronic limb-threatening ischemia

New analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Mechanical thrombectomy improves symptoms, quality of life in patients with pulmonary embolism

Six month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Largest chronic limb-threatening ischemia study provides insights for developing better process measures

Data from a cohort of one million patients with chronic limb-threatening ischemia (CLTI) were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Research projects aims to target underlying mechanisms to regain control over substance use

One of the main risk factors for death and disability worldwide is the use of intoxicants (alcohol, tobacco and illicit drugs). We know a great deal about the individual and social factors that influence the use of drugs.

19 May 2023

Researchers use machine learning to identify "synthetic extreme" DNA sequences

Artificial intelligence has exploded across our news feeds, with ChatGPT and related AI technologies becoming the focus of broad public scrutiny.

19 May 2023

High-risk heart attack patients could benefit from a long-term treatment with blood thinners

A new study examining the criteria proposed by the European Society of Cardiology (ESC) to prescribe long-term treatment with more than one blood thinner after percutaneous coronary intervention was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Medicine News and Research

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

Study helps clarify the underlying cause of chest symptoms in angina

Hand-gesture decoding using data from noninvasive brain imaging

Combining generative AI and quantum computing to accelerate drug discovery

TWILIGHT trial reveals the impact of DAPT and ticagrelor monotherapy after percutaneous coronary intervention

Study finds significant amount of clotting in the arteries of patients with STEMI and COVID-19

New Jersey's Medicaid reforms spurred increases in buprenorphine prescriptions to combat opioid addiction

Researchers discover sex-specific genes, molecular pathways that contribute to Alzheimer's disease progression

Study reports improved deliverability, tracking, and deployment of next-generation Evolut FX TAVR system

Tailored revascularization strategies can help improve outcomes for patients with chronic limb-threatening ischemia

Mechanical thrombectomy improves symptoms, quality of life in patients with pulmonary embolism

Largest chronic limb-threatening ischemia study provides insights for developing better process measures

Research projects aims to target underlying mechanisms to regain control over substance use

Researchers use machine learning to identify "synthetic extreme" DNA sequences

High-risk heart attack patients could benefit from a long-term treatment with blood thinners

Clinical trial tests effectiveness of chemotherapy after surgery for pancreatic neuroendocrine tumors

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Penn Medicine launches a new community mental health hub at Hospital of the University of Pennsylvania

Tirzepatide improves body composition across a range of adult age groups, study shows

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News